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PURPOSE: To compare the time-of-flight and contrast-enhanced- magnetic resonance angiography techniques in a 3
Tesla magnetic resonance unit with digital subtraction angiography with the latest flat-panel technology and 3D
reconstruction in the evaluation of embolized cerebral aneurysms.
INTRODUCTION: Many embolized aneurysms are subject to a recurrence of intra-aneurismal filling. Traditionally,
imaging surveillance of coiled aneurysms has consisted of repeated digital subtraction angiography. However, this
method has a small but significant risk of neurological complications, and many authors have advocated the use of
noninvasive imaging methods for the surveillance of embolized aneurysms.
METHODS: Forty-three aneurysms in 30 patients were studied consecutively between November 2009 and May 2010.
Two interventional neuroradiologists rated the time-of-flight-magnetic resonance angiography, the contrast-
enhanced-magnetic resonance angiography, and finally the digital subtraction angiography, first independently and
then in consensus. The status of aneurysm occlusion was assessed according to the Raymond scale, which indicates the
level of recanalization according to degrees: Class 1: excluded aneurysm; Class 2: persistence of a residual neck; Class 3:
persistence of a residual aneurysm. The agreement among the analyses was assessed by applying the Kappa statistic.
RESULTS: Inter-observer agreement was excellent for both methods (K = 0.93; 95 % CI: 0.84-1). Inter-technical
agreement was almost perfect between time-of-flight-magnetic resonance angiography and digital subtraction
angiography (K=0.98; 95 % CI: 0.93-1) and between time-of-flight-magnetic resonance angiography and contrast-
enhanced-magnetic resonance angiography (K=0.98; 95% CI: 0.93-1). Disagreement occurred in only one case
(2.3%), which was classified as Class I by time-of-flight-magnetic resonance angiography and Class II by digital
subtraction angiography. The agreement between contrast-enhanced-magnetic resonance angiography and digital
subtraction angiography was perfect (K = 1; 95% CI: 1-1). In three patients, in-stent stenosis was identified by
magnetic resonance angiography but not confirmed by digital subtraction angiography.
CONCLUSION: Digital subtraction angiography and both 3T magnetic resonance angiography techniques have
excellent reproducibility for the assessment of aneurysms embolized exclusively with coils. In those cases also
treated with stent remodeling, digital subtraction angiography may still be necessary to confirm eventual parent
artery stenosis, as identified by magnetic resonance angiography.
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INTRODUCTION
Intracranial aneurysms are a major health problem world-
wide, affecting 3-5% of the population with a prevalence
ranging from 1% to 6% in autopsy series in adults1-3 and
0.65% to 7% in angiographic series.3 Their treatment consists
of circulatory exclusion, thus avoiding the risk of bleeding.
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Initially, endovascular embolization was only considered
as an alternative therapy for aneurysms considered too risky4
or inaccessible to conventional surgical treatment.5 However,
with the rapid advent of new techniques and materials, the
use of endovascular embolization has been gaining ground.
This technique was globally recognized in 2002 with the
publication of the International Subarachnoid Aneurysm
Trial,6 which evaluated the results of conventional surgery
and endovascular embolization of ruptured aneurysms and
found a reduced risk of death and functional dependence for
patients undergoing endovascular treatment.
Despite all of the technical advances in the endovascular
field and the development of various endovascular devices,
it is known that some embolized aneurysms are still subject
to persistence of intra-aneurismal filling due to incomplete
initial treatment, re-growth of the aneurysm sac, or
reconfiguration of the coils inside the aneurysm. The most
accepted classification system for evaluation of recanaliza-
tion of aneurysms is that of Raymond et al.,7 which indicates
the level of recanalization according to degrees: Class 1,
excluded aneurysm; Class 2, persistence of residual neck;
and Class 3, persistence of residual aneurysm.
When present, the reconfiguration of the coils inside the
aneurysm can result in a recurrence of a residual aneurismal
neck or body,7,8 which leads to reperfusion of the aneurysm,
exposing the patient to the risk of rupture and bleeding.9
According to most studies, recurrence rates are around
14.7% to 33.6%.8 However, retreatment is necessary in only
10% to 15% of cases with embolized aneurysms.9,10
Therefore, imaging surveillance is very important for all
patients undergoing endovascular treatment of intracranial
aneurysms to identify aneurysm recurrence and to deter-
mine the subsequent need for retreatment.
Traditionally, the monitoring of embolized aneurysms
consisted of a repeated series of digital subtraction angio-
graphy (DSA) at intervals of months to years after emboliza-
tion. According to the protocol described by Piotin et al.,9
angiographic controls are ideally performed every 6, 18 and
36 months after treatment in the absence of aneurysm
recurrence. Since its introduction in 1980, DSA has under-
gone major innovations, such as the development of flat-
panel detector technology and 3D rotational angiography.
The use of flat-panel detectors (FPD) made it possible to
obtain images with higher resolution and definition.
Compared with the conventional imaging intensifier televi-
sion system, the FPD technology has several theoretical
advantages, such as high spatial resolution, wide dynamic
range, square field of view, and real-time imaging capabil-
ities with no geometric distortion.11,12 An additional advan-
tage is lower exposure to radiation with the FPD
technology.12 In a recent study, Ichida et al.13 assessed the
clinical impact of DSA with FPD and concluded that, in
general, FPD obtains better image definition and that,
particularly in cerebral vascular images, the resolution is
far superior than with a conventional imaging intensifier.
Therefore, the use of DSA, now with the FDP, might be
considered to be a reference method for vascular studies and
for imaging surveillance of embolized brain aneurysms, but
certain risks should be considered, such as a small but
important risk of neurological complications estimated to
occur in 0.3 to 1.8 % of cases.14,15 Additional disadvantages
include the need for a brief hospitalization after the
procedure, exposure to ionizing radiation, allergic and
nephrotoxic effects of the iodinated contrast media and the
risk of bleeding complications related to the arterial puncture
site, all in addition to the high cost of the procedure.14
Analyzing these drawbacks of DSA, many authors have
advocated a search for noninvasive imaging methods for the
surveillance of embolized aneurysms15-18 and for assessing
the feasibility of magnetic resonance imaging (MRI) as a
noninvasive method of choice.19-21 Similar studies22-26 have
reported a rather low agreement between methods; how-
ever, the equipment used in those studies was not the latest
technology available.
Our study aimed to compare time-of-flight (TOF) and
contrast-enhanced (CE-MRA) magnetic resonance angiogra-
phy (MRA) techniques in a 3 Tesla (T) magnetic resonance
unit with DSA with the latest flat panel technology and 3D
reconstruction for the evaluation of embolized cerebral
aneurysms.
MATERIALS AND METHODS
All patients were prospectively and consecutively included
in the study, following the clinical routine of the interventional
neuroradiology service of our institution, from November
2009 until the last patient enrolled in May 2010. At our
institution, all patients with cerebral aneurysms treated by
embolization undergo angiographic controls by DSA accord-
ing to the follow-up protocol of 6, 18 and 36 months after
embolization;27 therefore, it was not necessary to perform any
additional invasive exams for our research. On the day of the
scheduled DSA exam, the patient was submitted to an MRI
scan as authorized by written informed consent. In the case of
recanalization, the next angiographic surveillance exam was
shortened or a re-treatment decision was made. The Ethics
Committee of our institution approved the study.
Exclusion Criteria
The study excluded patients with a neurosurgical clip
located less than 20 mm from the embolized aneurysm.
Patients with pacemakers or who were younger than 18
years were also excluded from the study.
Patients and Aneurysms
Forty-three cerebral aneurysms were studied consecu-
tively in 30 patients, 23 women (76.7%) and 7 men (23.3%),
ranging from 27 to 74 years of age (mean age of 54.5 years
with a standard deviation of 11.2 years). Twenty patients
(66.6%) had a single aneurysm, eight (26.6%) patients had 2
aneurysms, 1 (3.3%) patient had three aneurysms and 1
(3.3%) patient had four aneurysms.
Thirty-four (79.07%) of the aneurysms were located in the
internal carotid, 6 (13.95%) in the vertebrobasilar system,
two (4.65%) in the middle cerebral artery and 1 (2.33%) in
the anterior communicating complex.
Of the 43 aneurysms studied, 15 (34.88%) were small
(, 7 mm), 12 (27.91%) medium (7 – 12 mm), 12 (27.91%)
large (12 – 25 mm) and 4 (9.30%) giant (. 25 mm). The
studied aneurysms were treated using simple techniques in
13 cases (30.23%), the balloon remodeling technique in 21
cases (48.83%) and the stent remodeling technique in 9 cases
(20.93%). All stents analyzed were Neuroform 3 stents
(Boston Scientific, Natick, Massachusetts).
DSA Technique
DSA was performed on a flat-panel detector system,
InnovaH 4100 (General Electric, Fairfield, Connecticut).
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Selective catheterization of the vessel nourishing the
aneurysm (internal carotid artery or vertebral artery) was
performed using a 5F catheter with an approach through the
femoral artery. Eight to ten milliliters of nonionic contrast
medium (iobitridol, henetixH 300, Guerbet, Roissy, France)
were injected into the internal carotid artery or vertebral
artery with an automated power injector (Mark V ProvisH
Medrad, Warrendale, PA) at 4 ml/s. Standardized poster-
ior-anterior and lateral views and the working view used at
the previous embolization were acquired. After reconstruc-
tion of a 3D rotational acquisition, a final injection was done
in the post-processed view, which better depicted the neck
of the aneurysm.
MRI Technique
MRI examinations were performed with a 3T unit (Philips
Achieva Duo - Philips Medical Systems, Best, The
Netherlands), using a standard head coil. MRA TOF 3D
was acquired in axial orientation using the following
parameters: field of view, 20 cm; TR/TE, 25/3.5 ms; flip
angle, 20 ;˚ matrix, 528 6 270; voxel size, 0.38 6 0.74 6
1.1 mm; reconstruction voxel size, 0.2 6 0.2 6 0.55 mm;
acquisition time, 7 m 5 s. CE-MRA at 3T was performed
using a 3D gradient sequence in coronal orientation with
the following parameters: field of view, 22 cm; TR/TE,
5.6/2.1 ms; flip angle, 27 ;˚ matrix, 5126384; voxel size, 0.96
0.960.9 mm; reconstruction voxel size: 0.660.660.9 mm;
acquisition time, 4 m 27 s.
CE-MRA images were acquired after administration of
gadobenate dimeglumine (ViewgamH, Lab. Bacon S.A.I.C.,
Buenos Aires, Argentina) at a dose of 0.1 mmol/kg (0.2 ml/
kg) body weight. Gadobenate dimeglumine was adminis-
tered to all patients through an antecubital vein at a rate of
2 ml/s using an MR-imaging-compatible power injector
(OptistarH LE, Mallinckrodt, Hazelwood, Missouri).
Image Evaluation
Two neuroradiologists (A: _____, B: _____) with experi-
ence in DSA and magnetic resonance imaging interpreted
the image sets for each method separately and indepen-
dently. Both readers had access to images of the DSA (2D
and 3D rotational DSA) pre- and post-embolization and to
the working view used during treatment. Treated aneur-
ysms in each image set were classified as described by
Raymond et al.7: class 1 = complete obliteration; class 2 =
residual neck; class 3 = residual aneurysm. None of readers
participated in any of the DSA procedures, and they only
gained access to the obtained angiography after classifying
the MRI image sets. Image analysis occurred in the
following order for all assessed aneurysms: TOF-MRA,
CE-MRA, DSA. This sequence was used to avoid any
possible interference from the memory of the DSA, which
was used as the reference method, in the assessment of the
corresponding image in MRA.
The need for image interpretation to rate the treated
aneurysm independently of the methods used to obtain the
image in this study allows us to anticipate some of the
limitations of the method. The use of equipment of the latest
technology, as in this study, produces the most accurate
images and minimizes the limitation. Thus, the real status
rating by any observer would be achieved only when the
images need only reading with no interpretation, which
demands either quantification or resolution and specificity.
The DSA images were processed and analyzed on an
Advantage WorkstationH Volumeshare2TM (General
Electric, Fairfield, Connecticut), while the MR images were
processed and analyzed on an Extended MR Workspace
2.6.3.1 SystemsH workstation (Philips). The MRA images
were evaluated using the source images, 3D maximum
intensity projection (MIP) and volume-rendered reconstruc-
tions targeted on the vessel of interest. The MRA images
were also qualitatively evaluated considering the conspi-
cuity of the residual patency, the contrast enhancement
achieved, and the presence of artifacts compromising the
aneurysm’s assessment or parent artery stenosis.
Statistics
Interobserver agreement between the readers was deter-
mined using the weighted Kappa statistic (K) with a
confidence interval of 95% and following the guidelines
suggested by Landis and Koch.28 After the blind study,
discrepancies were resolved by consensus. Finally, the
consensus data were also assessed using the weighted
Kappa statistic, comparing the agreement among methods
(TOF-MRA, CE-MRA and DSA). The interpretation of K
was as follows28: K = 0 indicated no agreement; K between
0–0.19, poor agreement; K between 0.20–0.39, fair agree-
ment; K between 0.40–0.59, moderate agreement; K between
0.60–0.79, substantial agreement; and K between 0.80–1.00,
almost perfect agreement. All of the analyses were
performed using SAS (Version 9.2) software (SAS Institute,
Cary, North Carolina).
RESULTS
In the studied cases, all of the MRA and DSA images were
of high quality. There were no clinical complications from
any imaging method.
Classification of Aneurysm Occlusion
Interobserver agreement for the classification of embo-
lized aneurysms was almost perfect (0.80-1.00) for all
methods, evaluated with K = 0.93 (95 % CI: 0.84-1)
(Figure 1). Disagreement in the Raymond’s classification
occurred in only three cases: one observer interpreted the 3
aneurysms as class I, class II and class II, whereas the other
reader classified them, respectively, as class II, class I and
class I.
Agreement between the TOF-MRA and DSA in the
identification of complete aneurismal occlusion, residual
aneurysm or a residual neck was almost perfect, with full
agreement in 42 aneurysms (97.6%), K = 0.98 (95% CI: 0.93-
1). Of the aneurysms equally classified by both methods, 23
(53.49%) were classified as completely occluded (class I), 5
(11.63%) with a residual neck (class II) and 14 (32.55%) with
persistent aneurysm (class III). Disagreement occurred in
only 1 case (2.33%), corresponding to a medium aneurysm
treated by balloon remodeling that was located in the
internal carotid artery; this aneurysm was classified as class
I by TOF-MRA and class II by DSA (Table 1). The agreement
between CE-MRA and DSA was perfect, with full agree-
ment in all 43 aneurysms (100%), K = 1 (95% CI: 1-1), with
the following classifications: 23 aneurysms (53.49%) were
classified as class I, 6 (13.95%) as class II, and 14 (32.56%) as
class III (Table 2). The correlation between TOF-MRA and
CE-MRA in the identification of complete aneurismal
occlusion, residual aneurysm or a residual neck was almost
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perfect, with full agreement in 42 aneurysms (97.6%), K =
0.98 (95% CI: 0.93-1). Of the aneurysms equally classified by
both sequences, 23 (53.49%) were classified as class I, 5
(11.63%) as class II, and 14 (32.56%) as class III.
Disagreement occurred in only 1 case (2.33%) (Figure 2),
which corresponded to the discordant case between TOF-
MRA and DSA. None of the 3D rotational DSA added new
information to the 2D DSA.
Artifacts
Enhancement of the venous structures was present in all
of the CE-MRA images. However, venous overlap did not
affect the image interpretation of any studied case.
High signal intensity, secondary to the presence of a clot
containing methemoglobin within a thrombosed aneurysm,
was identified by TOF-MRA in 2 aneurysms (4.65%). This
artifact was not observed close to the aneurysm’s neck area
in either case, therefore no prejudice in the interpretation of
the aneurysm’s occlusion status was identified.
In two large aneurysms of the internal carotid artery and
one giant basilar aneurysm, type III recanalization was
identified by all three methods (TOF-MRA, CE-MRA and
DSA). However, the aneurysm remnant was better visua-
lized in the CE-MRA images. In this method, the signal
intensity and conspicuity of the recanalization were higher
than for TOF-MRA. In these 3 cases, CE-MRA was also
better than DSA for visualization of the aneurysm remnant,
Figure 1 - Post-embolization follow-up of a cavernous carotid artery aneurysm, in working-view incidences, classified in consensus by
both readers as class II in Raymond scale. A: DSA of the internal carotid artery showing the residual neck of the treated aneurysm (class
II). B: DSA with 3D reconstruction delimiting the aneurysm residual neck (class II) and the coil mesh (arrow). C: CE-MRA with volume-
rendered reconstruction showing class II recanalization. D: TOF-MRA with volume-rendered reconstruction showing class II
recanalization.
Table 1 - Aneurysm occlusion status as assessed by DSA
and TOF-MRA, with Raymond’s classification, after
interobserver consensus.
TOF-MRA
DSA CI 95%
Class 1 Class 2 Class 3 K IL SL
Class 1 23(53.49) 1(2.33) 0(0.00) 0.98 0.93 1.00
Class 2 0(0.00) 5(11.63) 0(0.00)
Class 3 0(0.00) 0(0.00) 14(32.56)
IL: inferior limit; SL: superior limit; CI: confidence interval; DSA: digital
subtraction angiography; CE-MRA: contrast-enhanced magnetic
angiography.
Table 2 - Aneurysm occlusion status as assessed by DSA
and CE-MRA, with Raymond’s classification, after
interobserver consensus.
CE-MRA
DSA CI 95%
Class 1 Class 2 Class 3 K IL SL
Class 1 23(53.49) 0(0.00) 0(0.00) 1.00 1.00 1.00
Class 2 0(0.00) 6(11.63) 0(0.00)
Class 3 0(0.00) 0(0.00) 14(32.56)
IL: inferior limit; SL: superior limit; CI: confidence interval; DSA: digital
subtraction angiography; CE-MRA: contrast-enhanced magnetic
angiography.
Figure 2 - An internal carotid artery aneurysm with a small neck remnant identified by DSA and CE-MRA but not visible on TOF-MRA. A,
B: CE-MRA, with volume-rendered reconstruction of the internal carotid artery, showing a small aneurismal neck remnant (arrow). C, D:
TOF-MRA, with volume-rendered reconstruction of the internal carotid artery, without clear identification of the aneurismal neck.
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due to overlapping of the coil mesh repositioned on the
periphery of the aneurysm (helmet effect) (Figure 3).
In 3 cases of aneurysms treated with the stent remodeling
technique, we observed a decrease in signal intensity in the
vessel segment with the stent that assumed an appearance
suggestive of stenosis in both the CE-MRA and the TOF-
MRA but more pronounced in the latter sequence. None of
the three cases had stenosis when assessed by DSA (Figure 4).
DISCUSSION
Long-term follow-up is required for embolized aneur-
ysms to determine the stability of treatment and identify a
possible recanalization, which may require retreatment due
to the risk of bleeding. Considering the drawbacks inherent
to DSA,15,16 some authors have suggested MRI as a
noninvasive method of monitoring embolized cerebral
aneurysms.
In our study, we observed that the methods CE-MRA,
TOF-MRA and DSA have almost perfect agreement between
each other (K = 0.80 to 1.00) with excellent interobserver
reproducibility (K = 0.93; 95% CI: 0.84-1).
Interobserver disagreement was seen in only 3 cases
(6.9%). Different interpretation of the aneurysm occlusion
status between the two readers involved only disagreement
between Class 1 (completely occluded) and Class 2 (residual
neck) classifications. This interobserver disagreement had
no clinical consequence because it did not imply a different
therapeutic indication.
Inter-method disagreement was seen in only one case of a
medium aneurysm of the internal carotid artery. In this case,
DSA and CE-MRA identified a residual neck of less than
2 mm (class II), while TOF-MRA identified the aneurysm as
completely occluded (class I). Despite the different inter-
method classification for this aneurysm, no difference in
retreatment indication was observed. This is in agreement
with a study by Pierot et al. 20 where all false negative
results on MRI were the results of small residual necks
(2 mm or less), which would not have any therapeutic
consequences. Again, because the disagreement occurred
only with respect to the interpretation of small structures
when image resolution, definition, specificity are of utmost
importance, the idea of overcoming the limitations related
to the observers’ procedural protocol by refining the
technology gives support to the purpose of this study.
The necessity of having independent observers for image
rating raises subjectivity as a limitation in the method. To
some extent, the subjectivity was reduced by the high level
of experience of the observers with both of the methods
involved. However, the Raymond scale, which is widely
used, has itself some subjectivity in its classification, as its
rating is not based on measurements but rather on
descriptions of images. Thus, reducing or eliminating this
type of bias depends either on great experience or on high
Figure 3 - An ophthalmic aneurysm with an aneurismal remnant (class III), assuming a ‘‘helmet’’ type recanalization. A: DSA
demonstrating aneurismal remnant partially superimposed by the coil mesh. B: Angiography, without subtraction, showing the coil
mass surrounding the aneurism recanalization. C: CE-MRA with volume-rendered reconstruction showing the aneurysm remnant
without interposition of the coil mesh. D: TOF-MRA with volume-rendered reconstruction showing the aneurysm remnant without
interposition of the coil mesh but with slight loss of signal in comparison to CE-MRA.
Figure 4 - Follow-up of an aneurysm treated with a stent remodeling technique (Neuroform 3), assessing the patency of the parent
artery within the stent. A, B: CE-MRA and TOF-MRA, respectively, with volume-rendered reconstruction showing a focused loss of
signal, simulating an in-stent stenosis. C, D: DSA and DSA with 3D reconstruction showing a normal parent artery patency within the
stent.
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technology that produces images that more faithfully depict
the real anatomy.
Therefore, the agreement among methods found within
the observers combined with the disagreement between the
observers in the Raymond scale seems to demonstrate that
the bias is in the Raymond scale rather than in the imaging
strategy. Agreement by observers on the results using
different methods reinforces this study’s presumption that
use of the latest technology available reduces the subjectiv-
ity of the rating. Even if a time interval was set between the
readings of the image sets for each diagnostic exam for a
given patient, assuming that in this situation there would be
no interference from any recollection of the previous image,
the subjectivity of Raymond scale would still exist.
To the authors’ knowledge, this is the first study that
compares results obtained exclusively from the most
advanced equipment with the latest technology for each
imaging modality in the assessment of embolized aneur-
ysms.
Several authors have evaluated CE-MRA in comparison
to TOF-MRA, and many have reported superiority of the
former over the latter.17,19,29,30 CE-MRA has several theore-
tical advantages relative to TOF-MRA, such as the lower
susceptibility to turbulent flow and to saturation effects due
to the use of contrast medium, which produces a high-
intensity signal within the arterial lumen. Furthermore,
contrast enhancement provides increased conspicuity to
small vessels in regions of slow flow and improved
definition. Another disadvantage of TOF-MRA is the ‘‘T1-
shine-through’’ effect, which is intrinsic to the TOF
sequence and can appear as a high-intensity signal in
subacute or chronic thrombus inside the aneurysm, second-
ary to the presence of methemoglobin. In rare cases, this
effect can obscure the hyperintensity of residual flow within
the relevant vessel. CE-MRA is also less sensitive to coil or
stent-related artifacts.19
However, CE-MRA also has some disadvantages, such as
overlapping of venous structures due to the short time
window between both phases, leading to deterioration in
image quality, especially in cases of aneurysms located in
the middle cerebral artery or near the skull base.20,31 In our
study, all of the CE-MRA images had venous enhancement,
but there was no prejudice in assessing the status of
occlusion of the aneurysm in any case. Moreover, image
processing on the workstation removed undesired struc-
tures, allowing visualization of the embolized aneurysm at
different angles without interposition of venous structures.
Another disadvantage is the possibility of false positives for
aneurysm recanalization, resulting from peripheral
enhancement of an intra-aneurismal organized thrombus
or from the vasa-vasorum at the aneurysm wall,19,29 which,
however, was not observed in any of our cases. Finally, a
negative attribute of the use of gadolinium is the small but
important risk of nephrogenic systemic fibrosis.32
Despite the theoretical advantages of CE-MRA over TOF-
MRA, Kwee and Kwee,33 in a meta-analysis reviewing the
published data on the diagnostic performance of MRA in
the follow-up of embolized aneurysms, found no significant
statistical differences between both methods. Recently, a
multicenter study conducted by Schaafsma et al.34 corrobo-
rated the conclusion of the meta-analysis by not identifying
an important added value of CE-MRA over TOF-MRA.
Since the publication of Marjoie et al.22 reporting
the effectiveness of TOF-MRA for monitoring embolized
aneurysms, other studies have been published by Urbach et
al.,23 Buhk et al.35 and Ferre´ et al.24 demonstrating the
feasibility of this method as a first-line exam for coiled
aneurysm follow-up. The last-mentioned study, a recent
publication, showed excellent agreement (K = 0.86) between
3T TOF and DSA (non flat panel). Ramgren et al.36
concluded that TOF-MRA at 3T showed better agreement
with DSA than TOF-MRA at 1.5T and CE-MRA 3T. In
contrast, Anzalone et al.30 also evaluated both MRA
techniques in a 3T unit and found better depiction of
aneurismal recanalization in CE-MRA than TOF-MRA.
In a recent study, Kaufmann et al.37 concluded that larger,
clinically more important aneurysm remnants were better
characterized with CE-MRA at both 1.5T and 3T than with
TOF-MRA at 1.5T. In the analysis of our results, CE-MRA at
3T provided a better depiction of recanalized aneurysms
than TOF-MRA in 3 patients. However, the different
appearance of the embolized aneurysm using each method
did not imply a disagreement in the therapeutic approach to
be conducted. In these 3 cases, CE-MRA was even better
than DSA in demonstrating invaginated recanalization into
the mass of coils. In these cases, the mesh of spirals around
the aneurismal remnant acted as a radiodense ‘‘helmet’’,
which was partially penetrable to X-rays in DSA.25 In fact,
other reports have already suggested that MRA can be more
accurate than DSA in some circumstances.23,38 Both readers
acknowledged preference for the CE-MRA in the evaluation
of aneurysms with ‘‘helmet’’ recanalization. However, there
was no difference in the status classification of aneurysm
occlusion by any of three methods.
A limitation of our study is the small sample size of 43
aneurysms, of which 20 (46%) were incompletely occluded.
However, the latest single-center study published analyzing
the same methods (3T CE-MRA, 3T TOF-MRA and DSA not
performed in a flat-panel unit), enrolled only 12 incomple-
tely occluded aneurysms.39 In this study, TOF-MRA and
CE-MRA at 3T were equivalent in evaluating the occlusion
status of coiled intracranial aneurysms. Another limitation
that should be considered for further studies is that we did
not evaluate the 3D rotational angiography with coils digital
subtraction, which could especially improve the ‘‘helmet’’
recanalization assessment.
The nitinol self-expandable stent Neuroform evaluated in
our series was the first stent used to treat cerebrovascular
aneurysms.40 Before the availability of nitinol self-expand-
able stents, only balloon-expandable coronary stents were
available to assist the treatment of cerebral aneurysms by
stent remodeling. With the increased use of self-expandable
stents due to their better flexibility and navigation relative to
coronary stents, it became mandatory to monitor the
possibility of in-stent stenosis. Although in-stent stenosis
represents a common complication in atherosclerotic periph-
eral vascular disease, it is not expected at the same rates in
self-expandable intracranial stents deployed in a non-stenotic
vessel, as in the treatment of aneurysms.41 This is particularly
true given the low radial force of the Neuroform stent and the
non-use of associated balloon angioplasty, which thus results
in a low probability of endothelial trauma during and after
deployment. A study41 evaluating the follow-up of 156 cases
of cerebral aneurysm treated with Neuroform stent remodel-
ing embolization observed a rate of 5.8% for moderate to
severe (. 50%) in-stent stenosis. Although not very frequent,
the risk of in-stent stenosis is not negligible. Thus, the
imaging method used in the follow-up of aneurysms treated
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by stent remodeling should also assess the patency of the
main vessel.
Nehra et al.42 reviewed the safety and feasibility of 3T
MRI in the evaluation of the self-expanding nitinol stent and
confirmed the safety and efficacy of MRI in the evaluation of
the stent in an animal model. However, in studies involving
patients with aneurysms treated using a stent remodeling
technique, Lubicz et al.26 observed that the presence of an
intracranial stent can compromise the evaluation of patency
of the main vessel at 1.5 T MRI. In this study, in-stent signal
loss was present in all TOF-MRA cases but was not
observed in CE-MRA images. Lovblad et al.43 also found
better definition in CE-MRA for evaluating the parent artery
lumen within the stent. This study also observed lower
susceptibility to artifacts in Neuroform stents than in
stainless steel stents. For the detection of residual aneur-
ysms, Lubicz et al.26 found that in five patients with
recanalization of the aneurysm treated using a stent
remodeling technique, 3 recanalizations were not detected
by TOF-MRA, but all were well characterized by CE-MRA
and DSA.
In our study of 9 patients treated using a stent remodeling
technique, all of the patients were classified under the same
status of aneurysm occlusion by all three methods.
Regarding the patency of the main vessel within the stent,
we had the same impression as Lovblad et al.43 and Lubicz
et al.,26 concluding that the parent vessel definition was
better in CE-MRA than in TOF-MRA. However, in three
cases in our study, both TOF-MRA and CE-MRA showed
parent artery stenosis within the stent, which was more
pronounced in TOF-MRA, and none of the stenosis was
confirmed by DSA.
The necessity of having independent observers for rating
of images raises subjectivity as a limitation in the method.
To some extent, that subjectivity was reduced by the high
level of experience of the observers with both of the
methods involved. However, the Raymond scale, which is
widely used, itself has some subjectivity in its classification,
as its rating is based not on measurements but on
descriptions of images. Thus, reducing or eliminating this
type of bias depends either on great experience or on high
technology that produces images that more faithfully depict
the real anatomy.
Therefore, the agreement found within the observers
using the different methods, along with the disagreement on
the Raymond scale classification, seems to demonstrate that
the bias is in the Raymond scale rather than in the method of
obtaining the images. Agreement by the observers on the
results of the different methods reinforces this study’s
presumption that the use of the latest technology available
reduces the subjectivity. Even when setting a time interval
between the readings of the image set for each diagnostic
exam for a given patient, assuming that in this situation
there would be no interference from any recollection of the
previous image, the subjectivity of Raymond scale would
still exist.
CONCLUSION
In our study, DSA with flat-panel technology and 3T MRI
techniques showed similar assessments of aneurysm occlu-
sion after embolization. However, in cases treated with stent
remodeling, DSA may still be necessary to confirm an
eventual parent artery stenosis within the stent identified by
MRI. In three cases, there was better characterization of the
embolized cerebral aneurysms by CE-MRA than by TOF-
MRA and even DSA. However, no difference was observed
in the indication of retreatment by each method.
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